Effects of lactulose supplementation on performance, blood profiles, excreta microbial shedding ofLactobacillusandEscherichia coli, relative organ weight and excreta noxious gas contents in broilers
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
This study was to evaluate the effects of lactulose supplementation on performance,
blood profiles, excreta microbial shedding of Lactobacillus and Escherichia coli,
relative organ weight and excreta noxious gas contents in broilers. A total of 720
ROSS 308 broilers with a body weight of 46 ± 0.1 g (1 day of age) were used in a 28-d
experiment. Broilers were randomly allotted to 4 experiment diets with 12 replicate
pens and 15 birds per pen. Dietary treatments were as follows: NC, negative control
(without antibiotic); PC, NC + 0.1% tiamulin; L1, NC + 0.1% lactulose; and L2, NC
+ 0.2% lactulose. Broilers were fed with phase 1 (1-8 day), phase 2 (9-18 day) and
phase 3 (19-28 day) diets in the form of mash. During day 1-8, broilers fed the PC
and L2 diets had higher (p < 0.05) body weight gain than those fed the NC diet. During
day 19-28, broilers fed the L1 and L2 diets had lower (p < 0.05) feed intake than
those fed the NC diet. The feed conversion ratio (FCR) was decreased (p < 0.05) in
L1 treatment compared with NC treatment. Overall, the FCR was improved (p < 0.05)
in all supplementation treatments compared with NC treatment. The apparently metabolizable
nitrogen in L1 treatment was higher (p < 0.05) than that in NC treatment at day 28.
The excreta Lactobacillus was increased and E. coli was decreased in PC and L2 treatments
compared with NC treatment at day 28 (p < 0.05). The excreta NH3, H2S and acetic acid
contents were decreased (p < 0.05) in L1 and L2 treatments compared with NC treatment.
The relative weight of abdominal fat of broilers fed the PC diet was lowest (p < 0.05)
compared with other treatments. In conclusion, this study indicated that dietary supplementation
of 0.1% or 0.2% lactulose could improve growth performance, decrease excreta E. coli
and excreta NH3 and H2S contents.
Oligofructose and inulin are naturally occurring indigestible carbohydrates. In vitro they selectively stimulate the growth of species of Bifidobacterium, a genus of bacteria considered beneficial to health. This study was designed to determine their effects on the large bowel microflora and colonic function in vivo. Eight subjects participated in a 45-day study during which they ate controlled diets. For the middle 15 days, 15 g.day-1 oligofructose was substituted for 15 g.day-1 sucrose. Four of these subjects went on to a further period with 15 g.day-1 inulin. Bowel habit, transit time, stool composition, breath H2 and CH4, and the predominant genera of colonic bacteria were measured. Both oligofructose and inulin significantly increased bifidobacteria from 8.8 to 9.5 log10 g stool-1 and 9.2 to 10.1 log10 g stool-1, respectively, whereas bacteroides, clostridia, and fusobacteria decreased when subjects were fed oligofructose, and gram-positive cocci decreased when subjects were fed inulin. Total bacterial counts were unchanged. Fecal wet and dry matter, nitrogen, and energy excretion increased with both substrates, as did breath H2. Little change in fecal short-chain fatty acids and breath CH4 was observed. A 15-g.day-1 dietary addition of oligofructose or inulin led to Bifidobacterium becoming the numerically predominant genus in feces. Thus, small changes in diet can alter the balance of colonic bacteria towards a potentially healthier microflora.
The ability of different enteric pathogens and coliforms to trigger agglutination of yeast cells (Saccharomyces cerevisiae, NCYC 1026) and a yeast cell wall preparation (MOS) was examined. Five of seven strains of Escherichia coli and 7 of 10 strains of Salmonella typhimurium and Salmonella enteritidis agglutinated MOS and Sac. cerevisiae cells. Strains of Salmonella choleraesuis, Salmonella pullorum, and Campylobacter did not lead to agglutination. Two strains that agglutinated MOS (S. typhimurium 29E and Salmonella dublin) and one nonagglutinating strain (S. typhimurium 27A) were selected as challenge organisms for in vivo studies in chicks under controlled conditions. In a series of three trials in which 3-d-old chicks were orally challenged with 10(4) cfu of S. typhimurium 29E, birds receiving 4,000 ppm of dietary MOS had reduced cecal S. typhimurium 29E concentrations (5.40 vs 4.01 log cfu/ g; P < 0.05) at Day 10. In a second series of three trials with S. dublin as challenge organism, the number of birds that tested salmonella positive in the ceca at Day 10 was less when MOS was part of the diet (90 vs 56%; P < 0.05). To test the effect of MOS on concentrations of bacteria that do not express Type 1 fimbriae, a challenge trial was conducted with S. typhimurium 27A. However, strain 27A did not colonize the birds sufficiently to evaluate whether MOS affected its cecal concentration. Mannanoligosaccharide did not significantly reduce the concentrations of cecal coliforms (P < 0.10) although they were numerically lower. It had no effect on cecal concentrations of lactobacilli, enterococci, anaerobic bacteria, lactate, volatile fatty acid, or cecal pH.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.